MediXall (MDXL) Invested Capital (2019 - 2024)
MediXall's Invested Capital history spans 8 years, with the latest figure at -$3.4 million for Q3 2024.
- For Q3 2024, Invested Capital fell 114.96% year-over-year to -$3.4 million; the TTM value through Sep 2024 reached -$3.4 million, down 114.96%, while the annual FY2023 figure was -$2.7 million, 141.86% down from the prior year.
- Invested Capital reached -$3.4 million in Q3 2024 per MDXL's latest filing, down from -$3.1 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $1.0 million in Q1 2021 to a low of -$3.4 million in Q3 2024.
- Average Invested Capital over 5 years is -$865244.3, with a median of -$424976.0 recorded in 2022.
- Peak YoY movement for Invested Capital: surged 1011.03% in 2021, then crashed 1043.53% in 2022.
- A 5-year view of Invested Capital shows it stood at $381904.0 in 2020, then crashed by 189.06% to -$340122.0 in 2021, then plummeted by 227.4% to -$1.1 million in 2022, then plummeted by 141.86% to -$2.7 million in 2023, then fell by 27.77% to -$3.4 million in 2024.
- Per Business Quant, the three most recent readings for MDXL's Invested Capital are -$3.4 million (Q3 2024), -$3.1 million (Q2 2024), and -$2.8 million (Q1 2024).